IngentaConnect Ozone Therapy in Cancer Treatment: State of the Art

Authors: Menendez, Silvia¹; Cepero, Janet²; Borrego, Luis³

Source: Ozone: Science and Engineering, Volume 30, Number 6, November 2008 , pp. 398-404(7)

Abstract:

Erhlich Ascitic Tumor and Sarcoma 37 were implanted in mice and afterward the animals were treated with ozone (rectally). A significant decrease in the number of metastasis was obtained. In another study, ozone was applied intraperitoneally, before Lewis' lung carcinoma inoculation. A delayed effect in the tumor development kinetics and in the increase rate of tumor volume in the ozone groups was observed. With regard to the clinical trial, patients with prostatic cancer were treated with cobalt-60 therapy and ozone (rectally), decreasing the presence of side effects (due to radiation treatment) and the prostatic specific antigen figures. However, further investigations are necessary to be performed, in order to be considered the ozone therapy as complementary therapy for cancer.

Keywords: Ozone; Prostatic Adenocarcinoma; Metastasis; Chemotherapy; Radiotherapy; Lewis' Lung Carcinoma; Sarcoma 37; Erhlich Ascitic Tumor

Document Type: Research article

DOI: 10.1080/01919510802473724

Affiliations: 1: Ozone Research Center, Havana, Cuba 2: National Oncology and Radiobiology Institute, Havana, Cuba 3: ˙˙V. I. Lenin˙˙ Provincial Hospital, Holguin, Cuba

The full text electronic article is available for purchase. You will be able to download the full text electronic article after payment.

$45.09 plus tax